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Telomeres are essential for genomic integrity, but little is known about their regulation in the normal human mammary gland. We now
demonstrate that a phenotypically defined cell population enriched in luminal progenitors (LPs) is characterized by unusually short
telomeres independently of donor age. Furthermore, we find that multiple DNA damage response proteins colocalize with telomeres
in >95% of LPs but in <5% of basal cells. Paradoxically, 25% of LPs are still capable of exhibiting robust clonogenic activity in vitro.
This may be partially explained by the elevated telomerase activity that was also seen only in LPs. Interestingly, this potential telomere
salvagemechanismdeclineswith age.Our findings thus revealmarked differences in the telomere biology of different subsets of primitive
normal human mammary cells. The chronically dysfunctional telomeres unique to LPs have potentially important implications for
normal mammary tissue homeostasis as well as the development of certain breast cancers.INTRODUCTION
Chromosome ends, referred to as telomeres, contain repeat
sequences (TTAGGG)n and associated proteins that protect
cells from the formation of chromosome end-to-end
fusions (Artandi and DePinho, 2010). In normal tissues,
such as in the hematopoietic system, where cell turnover
is high andcontinuous throughout life, telomeres aremain-
tained in the most primitive cells at relatively long lengths
and then become progressively shorter as the cells differen-
tiate through multiple amplifying divisions and with age
(Aubert and Lansdorp, 2008). Epithelial tissues, including
the mammary gland in both humans and mice, also un-
dergo extensive turnover, and recent studies indicated
that this may involve a similarly organized hierarchical
differentiation process (Eirew et al., 2008; Visvader, 2009).
To date, analysis of telomere length regulation in normal
mammary epithelial cells has been limited to reports of
shorter telomeres in luminal cells (Kurabayashi et al.,
2008; Meeker et al., 2004), and human telomerase reverse
transcriptase (hTERT) messenger RNA (mRNA; Kolquist
et al., 1998) in histological sections. However, the presence
of telomere fusionswas noted in primarymammary epithe-
lial cells after their extensive passage in vitro (Romanov
et al., 2001), and we recently reported that telomere-
dysfunction-specific chromosomal fusions are common
in early-stage breast cancers (Tanaka et al., 2012). Here
we show that phenotypically separable compartments of28 Stem Cell Reports j Vol. 1 j 28–37 j June 4, 2013 j ª2013 The Authorsnormal humanmammary epithelial cells with distinct bio-
logical properties havemarkedly different telomere lengths
and telomerase activities. Interestingly, a phenotype that
is highly enriched in luminal progenitors (LPs) is uniquely
characterized by critically short telomeres, frequent evi-
dence of a telomere-specific DNA damage response (DDR),
and an age-related decrease in telomerase activity.RESULTS AND DISCUSSION
Normal Human Mammary LPs Possess Short
Telomeres
To examine telomere length in different compartments of
normal human breast tissue and possible age-related
changes, we isolated four phenotypically distinct subsets
of cells at highpurities (>95%) fromdifferent normal reduc-
tionmammoplasty tissue samples obtained from donors of
different ages and analyzed them directly, without culture
(Figure 1A; Table S1 available online). We examined
four subsets of cells: (1) a basal epithelial cell (BC) subset
that is highly enriched in cells with bipotent as well as
myoepithelial clonogenic activity in vitro (Figure 1B), (2)
an LP subset that is similarly enriched in cells with luminal
clonogenic activity in vitro (Figure 1B), (3) a third mam-
mary epithelial cell subset that contains exclusivelymature
luminal cells (LCs) with no clonogenic activity (Figure 1B),
and (4) a population consisting of nonepithelial stromal
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Figure 1. Telomere Length Alterations in Different Subsets of Cells Present in Normal Human Breast Tissue
(A) Process for isolating and characterizing the four subsets of cells studied (after removal of CD45+ hematopoietic and CD31+ endothelial
cells), showing examples of colonies obtained from cells in the LP (above) and BC (below) fractions. BCs are defined by their
CD49fhiEpCAMneg/low phenotype and contain bipotent and self-renewing mammary stem cells identified by in vivo transplantation assays
(legend continued on next page)
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Telomere Dysfunction in Breast Luminal Progenitorscells (SCs) that are still prominent after the hematopoietic
and endothelial cells are removed (Figure 1A). Extracts of
each of these four highly purified cell populations were
analyzed for telomere length both by quantitative phos-
phorimage scanning of telomere restriction fragment
(TRF) lengths in southern blots (Aviv et al., 2011; Cawthon,
2009) and by quantitative PCR (qPCR; Aviv et al., 2011;
Cawthon, 2009; Figures 1C–1G). To evaluate telomere
length values for individually analyzed cells in the BC and
LP subsets, we used flow-fluorescent in situ hybridization
(Flow-FISH) to examine freshly isolated cells (Rufer et al.,
1998; Figure1H)andquantitative FISH (Q-FISH) to examine
metaphases obtained on the proliferating progeny of LPs
and BCs present in 3-day adherent cultures of these cells
(Poon et al., 1999; Figures 1I and 1J). The striking finding
from all of these analyses is the very short average telomere
length that uniquely characterizes LP cells, regardless of the
age of the donor. The southern data imply that some chro-
mosomes within the LP population likely contain TRFs <3
kb in length (Figure 1F) and this was also evident from the
Q-FISH data (Figure 1J). This telomere length has been asso-
ciated with telomere dysfunction and cell death in the
absence of telomerase (Begus-Nahrmann et al., 2012; He-
mann et al., 2001). By comparison, the average telomere
length of the BCs is considerably longer (6–8 kb) and
also age independent. However, the importance of age as
a variable is evident in the terminally differentiated LCs
(Figure 1C). Analyses of the matching SCs showed that
these cells contain even longer telomeres than any of the(Eirew et al., 2008; Lim et al., 2009). BCs also include CFCs that generat
as CFCs that generate pure myoepithelial cell colonies (myoepithelial C
The CD49fhiEpCAMhi fraction contains mammary cells with features of lu
high frequency (Raouf et al., 2008) and accordingly is referred to here
phenotype and are referred to as LCs because they are devoid of growth
developmentally downstream of LPs. Note the color code adopted for
(B) CFC frequencies in the phenotypically defined BC, LP, and LC fracti
measurements by southern blot (closed circles).
(C) TRF length measurements for the different subsets as a function o
(D) Correlation of the average TRF length measured by southern blot
samples).
(E) Representative southern blot showing the spread of TRFs obtaine
mammary cells (epithelial-enriched cells [EECs] and total breast cells [
very short telomeres. To the right are distributions of TRFs shown as a
represented in the adjacent southern blot.
(F) TRF lengths for each of the four subsets from southern blots (mea
(G) qPCR telomere lengths measured for each of the four subsets (me
using a paired two-tailed Student’s t test.
(H) Representative Flow-FISH plots of telomere-specific fluorescein
BCs and LPs compared with a spiked-in calf thymocyte standard. The a
8.9 ± 0.4 and 7.9 ± 0.3, respectively (p < 0.05, one-tailed Student’s
(I) Q-FISH-stained chromosomes of representative BC and LP metaph
channel is labeled as green.
(J) Frequency distribution of telomere fluorescence levels measured o
colcemid for 2 hr). Mean telomere length was calculated as described
30 Stem Cell Reports j Vol. 1 j 28–37 j June 4, 2013 j ª2013 The Authorsmammary epithelial cells (on average 9 kb by southern
blot analysis), and also do not show significant changes in
telomere length with age (Figures 1C and 1E–1G).
The age-related changes in telomere length observed in
the isolated LCs were masked in southern analyses of
DNA extracts obtained from unseparated breast tissue
(Figure 1E, lane marked TC). This likely reflects the low
representation of the LCs in whole breast tissue relative
to the predominance of other cells (Figure 1A) regardless
of donor age. The discovery of short telomeres specific to
the LP compartment is notable given that a high propor-
tion of cells with an LP phenotype (up to 48%; Figure 1B)
can execute multiple divisions in vitro.
LPs Display Evidence of a Telomere-Associated DDR
without Telomere Fusions
To determine whether the short telomeres characteristic
of normal human LPs are sufficient to elicit a DDR, we
first performed microarray analyses on RNA extracted
from BC, LP, and LC populations purified from young
(premenopausal, 20–49 years old, n = 6) and older donors
(postmenopausal, 59–68 years old, n = 3). Unsupervised
hierarchical clustering of the data demonstrated that
the cell subset, but not donor age, was a strong classifier
(Figure 2A). Examination of genes associated with mam-
mary cell differentiation confirmed both expected and
novel associations (Figures 2B and 2C). For example, BCs
expressed the highest levels of transcripts for smooth mus-
cle actin (ACTA2), TP63,NOTCH4, keratin 4 (KRT4), KRT5,e mixtures of luminal and myoepithelial cells (bipotent CFCs) as well
FCs) and ‘‘mature’’ myoepithelial cells that do not have CFC activity.
minal cells as well as CFCs that produce pure luminal cell colonies at
as the LP fraction. The third subset of cells have an CD49floEpCAMhi
activity in either in vivo or in vitro assays and are considered to be
all subsequent figures: blue, BCs; red, LPs; orange, LCs; gray, SCs.
ons of 12 of the samples, including several used for telomere length
f donor age (n = 13).
and qPCR analysis of 28 different DNA extracts (12 different donor
d from BCs, LPs, LCs, and SCs, as well as from initial unseparated
TCs]), and HT1080, a human tumorigenic fibrosarcoma cell line with
percentage of the maximum telomere probe signal for the examples
n ± SEM, 13 different donor samples).
an ± SEM, seven different donor samples); p values were calculated
-conjugated (CCCTAA)3 PNA fluorescence in individually assessed
verage modal values from three matched pairs of BCs and LPs were
t test).
ases. The DAPI channel is labeled as gray and the telomere probe
n 15 metaphases from 3-day cultures of BCs and LPs (treated with
previously (Poon et al., 1999).
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Figure 2. Distinct Expression Profiles of Telomere-Associated Genes in Normal Mammary Epithelial Subpopulations
(A) Unsupervised hierarchical clustering of gene-expression data from microarray analyses of purified cell fractions.
(B) Unsupervised hierarchical clustering of gene-expression profiles of known lineage markers. A heatmap (yellow = upregulated, black =
downregulated) demonstrates the relative expression of each marker gene.
(C) Venn diagram showing the numbers of significantly (p < 0.05) differently expressed genes between different subset pairs.
(D) Telomere-associated gene-expression profiles of the BC and LP subsets. The top 50 differentially expressed telomere-associated genes
identified by a search in GO were used to classify BCs and LPs using an unsupervised clustering algorithm.
(E) qRT-PCR of DDR gene transcript levels from four samples.
(F) qRT-PCR of senescence-associated gene transcripts from five to eight samples. Error bars represent mean ± SEM; p values were
determined by a paired two-tailed Student’s t test.
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Telomere Dysfunction in Breast Luminal ProgenitorsKRT14, KRT17, vimentin, THY1, and CD44, which are all
established BC markers. Similarly, LPs and LCs expressed
higher levels of transcripts than the BCs for many known
luminal markers (CD24, MUC1, KRT18, KRT19, EPCAM,
NOTCH3, andGATA3). LPs also expressed the highest levels
of prominin1 (CD133), KIT, and ALDH1A transcripts, as
predicted by the literature (Eirew et al., 2012; Lim et al.,
2009; Raouf et al., 2008). LCs expressed the highest levels
of ZNF703 (Holland et al., 2011), estrogen receptor-a
(ESR1), trefoil factor 3 (TFF3), and KRT8, which have
been associated with luminal-type mammary cancers
(Lim et al., 2009). The progenitor-enriched BC and LP sub-
sets also displayed increased epidermal growth factor recep-
tor (EGFR) transcripts consistent with their requirement for
EGF to support their clonogenic activity in vitro.
Using the Gene Ontology (GO) database (http://www.
geneontology.org), we identified 50 telomere-associated
genes that are expressed in LPs at significantly different
levels than in BCs (Figure 2D). Expression of 13 of these
genes was elevated in LPs, and these included several
DDR genes (MRE11, RAD50, ATM, ATR, and BLM). ATM is
the primary activator of DNA double-strand break repair
and requires the early initiation factor MRN complex that
is composed of MRE11, RAD50, and NBS1 (Uziel et al.,
2003). Higher expression of MRE11, RAD50, ATM, ATR,
and BLM in LPs as compared with BCs was confirmed
in quantitative RT-PCR (qRT-PCR) analyses of additional
samples (Figure 2E). In contrast, RAP1 and DNA-PK were
more highly expressed in the BCs.
DDR gene products in the MRN complex have identi-
fied roles in the repair of DNA double-strand breaks (van
den Bosch et al., 2003) and have also been reported to
localize at telomeres following induction of telomere
dysfunction in various cell line models (Stracker and
Petrini, 2011). To determine whether LPs and BCs
would show differences in telomere-associated DDR
sensors, we fixed freshly isolated LPs and BCs; stained
them with antibodies to NBS1, RAD50, g-H2AX, 53BP1,
MRE11, and TRF2 (a protein that specifically localizes
to telomeres [Tomlinson et al., 2006] and also served as
a permeabilization control); and then examined indi-
vidual nuclei by confocal imaging. Importantly, in spite
of the lower levels of TRF2 transcripts in LPs, TRF2 protein
could be readily detected immunochemically at telomere
foci in these cells as well as in BCs. We found that
NBS1, RAD50, g-H2AX, and 53BP1 were essentially unde-
tectable in the nuclei of BCs but strongly present in the
nuclei of all LPs examined, where they were consistently
colocalized with TRF2 (10 telomere dysfunction-induced
foci [TIFs] per LP nucleus; Figures 3A–3C). MRE11 was
detectable and colocalized with TRF2 in some BC nuclei,
but significantly less so than in LP nuclei (p < 0.00001;
Figure 3). The MRE11 present at the telomeres of32 Stem Cell Reports j Vol. 1 j 28–37 j June 4, 2013 j ª2013 The AuthorsBCs may reflect the known role of MRE11 in conven-
tional telomere maintenance (Zhu et al., 2000). In
contrast, the high levels of g-H2AX, 53BP1, and other
early DDR proteins at the telomeres of LPs suggests that
throughout adult life, at least some of these cells experi-
ence biologically significant consequences of telomere
dysfunction.
Interestingly, however, neither telomere-associated
repeat (TAR)-fusion PCR analyses (Tanaka et al., 2012)
of freshly isolated LPs and BCs (Figure 3D) nor exami-
nation of the metaphases prepared for the Q-FISH
analyses from the LPs (and BCs) revealed any evidence
of telomere fusions (Figure 1I). This suggests that the
very short telomeres of at least some cells in the LP
compartment must prevent their further progression
through the cell cycle, and possibly explains why higher
frequencies of LPs with in vitro clonogenic activity
have not been achievable (Eirew et al., 2008; Raouf et al.,
2008; Figure 1B). It was previously suggested that main-
tenance of mammary epithelial cells in vitro leads to
a progressive increase in TIFs, with the induction of
senescence following the accumulation of five or more
TIFs per cell (Kaul et al., 2012). As with replicative cellular
senescence, telomere shortening and cellular responses
to consequent DNA damage may thus act primarily
as a tumor-suppressive mechanism in mammary LPs
(Campisi, 2011).
Although senescence programs relevant to human cells
in vivo have not yet been established, increased lysosomal
content and altered expression of several genes have both
been associatedwith senescence in various cell linemodels.
Fluorescence-activated cell sorting (FACS) analysis of LPs
and BCs with LysoTracker dye showed the LPs to have a
higher lysosomal content (Figure S1). Likewise, higher
expression of P14, P53, PML, ID2, and E2F1, and decreased
expression of TBX2 and TBX3 (genes designated as senes-
cence associated in GO) were also evident in our present
and previously published transcriptome data sets (Figures
S2 and S3). These gene-expression findings were confirmed
by qRT-PCR (Figure 3F).
Thus, LPs may be predisposed to events that confer
oncogenic properties on cells that acquire critically
short telomeres, but appear to be protected from such
events, at least to some extent, by activation of mecha-
nisms that cause them to exit the cell cycle and/or senesce.
The short telomere length of the LPs and their high
frequency of TIFs may be particularly relevant in light
of recent studies that implicated these cells in the develop-
ment of BRCA1-associated breast cancers, and showed that
malignant cells had a transcriptional profile similar to that
of normal LPs even though they exhibited a BC phenotype
(Lim et al., 2009; Proia et al., 2011). Since an association of
short telomeres with increased sensitivity to other sources
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Figure 3. Detection of TIFs in the Nuclei of Normal Human Mammary LPs but Not BCs
(A) Upper panels: Representative images of single BC and LP nuclei, showing differential colocalization of TRF2 with NBS1, MRE11, RAD50,
g-H2AX, and 53BP1. Middle panels: The total number of TIFs per nucleus (>50 nuclei examined for each DDR gene). Lower panels: The
frequency of affected BC and LP nuclei, with average values indicated by the black bars in each case.
(B) Representative images of BCs and LPs, showing differential colocalization of g-H2AX with 53BP1. The total numbers of g-H2AX/53BP1
foci in LPs and BCs are presented in dot plots and the average values are shown as black bars.
(C) Frequency of BCs and LPs displaying colocalized foci of NBS1, MRE11, RAD50, g-H2AX, and 53BP1 with TRF2.
(D) TAR-Fusion PCR performed on BCs and LPs isolated from four different samples obtained from donors of various ages. Positive
control: DNA from human BJ E6/E7 foreskin fibroblast cells with telomere crisis. Negative control: DNA from primary human BJ foreskin
fibroblast.
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Telomere Dysfunction in Breast Luminal Progenitorsof DNA damage has been reported (Berardinelli et al., 2012;
Wong et al., 2000), it will be of interest to determine
whether this extends to LPs or whether other mechanisms
override such a relationship.
hTERT Expression and Telomerase Activity
Are Upregulated in LPs but Decline with Age
hTERT, the catalytic (and limiting) component of telome-
rase activity, is absent from most differentiated somatic
human cells (Shay and Bacchetti, 1997), including normal
breast tissue (Shay and Bacchetti, 1997; Tanaka et al.,
2012). Given our finding of short telomeres and evidence
of a DDR in the LPs, we asked whether hTERT expression
and activity are detectable in these cells (Figure 4). Using
the telomere repeat amplification protocol (TRAP) assay(Herbert et al., 2006), we found that the level of telomerase
activity in LPs approached that previously observed in
telomerase-dependent malignant HeLa cells (Shay and
Wright, 2010), but detected no activity in the three other
subsets (Figures 4A and 4B). Interestingly, the telomerase
activity in LPs was particularly elevated in younger women
and then declined 5-fold with age (Figure 4C), consistent
with the parallel age-associated reduction of LC telomere
length (Figure 1C). qRT-PCR measurements of hTERT
mRNA levels (Figure 4D) and confocal imaging of telo-
mere-associated hTERT expression (Figures 4E and 4F)
confirmed that hTERT expression in the LPs was consis-
tently (80% of LPs) and selectively elevated (Figure 4D).
These studies also show that the hTERT present in LPs
is associated with their telomeres, as evidenced by theStem Cell Reports j Vol. 1 j 28–37 j June 4, 2013 j ª2013 The Authors 33
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Figure 4. Telomerase Expression and
Activity in Normal Human Mammary
Epithelial Cell Subsets
(A) Representative gel comparing the telo-
merase activity of BCs, LPs, LCs, and SCs
assessed by the TRAP assay using non-
denatured lysates of HT1080 and HeLa cells
as a positive control, and heat-inactivated
(HI) cellular lysate and CHAPS detergent
buffer in the absence of cellular lysate as
negative controls. IC, internal control.
(B) Comparison of TRAP activity measure-
ments obtained on all four subsets from
all 12 samples analyzed expressed as a
percentage of the activity in HeLa cells.
Values shown are the mean ± SEM.
(C) Distribution of the individual telome-
rase activity measurements shown in (B),
but displayed for each subset as a function
of the age of the donor. The p value shows
age association significance.
(D) hTERT transcript levels measured by qRT-
PCR analyses of each of the four subsets by
comparison with HeLa cells. Extracts of BCs,
LCs, SCs, and mammary DAPICD31+CD45+
(LIN) cells (three samples) did not contain
detectableRNA levels. Values shown for LPs are
the mean± SEM from the same three samples.
(E) Representative confocal laser micro-
scope images of the nuclei of purified
permeabilized BCs and LPs stained with
SYTOX Blue and differently labeled anti-
bodies to hTERT (in red) or TRF2 (green), or
both. Colocalized foci are yellow.
(F) Frequency of BC and LP nuclei that demonstrated colocalized hTERT+TRF2+ foci (yellow). Values are the mean ± SEM
of multiple nuclei from three different donors (p < 0.0001, paired two-tailed Student’s t test).
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imately three foci per nucleus in 80% of the LPs; Figures
4E and 4F).
The decreasing levels of telomerase activity seen in
the LPs of older women is not inconsistent with the age-
independent telomere lengths of LPs because the latter
are likely sustained long term by their continuous deriva-
tion frommore primitive cell types in the BC compartment
(Eirew et al., 2008). Additionally, LP cells with critically
short telomere lengths may be eliminated by exit from
the cell cycle through a senescence pathway (Campisi,
2011; Hemann et al., 2001). However, the decreasing levels
of telomerase activity seen in the LPs of older women may
affect their ability to generate LCs, since LPs are thought
to be LC precursors. On the other hand, the relatively
high levels of telomerase activity found in LPs may have
novel, telomere-length-independent roles, as suggested
by others (Elenbaas et al., 2001; Hemann et al., 2001;34 Stem Cell Reports j Vol. 1 j 28–37 j June 4, 2013 j ª2013 The AuthorsKiyono et al., 1998; Park et al., 2009; Sharma et al., 2003;
Smith et al., 2003).
Our findings also raise the interesting possibility that
the changes in telomere length regulation and their
sequelae in the LP subset of cells in the normal human
mammary gland may occur in the transit-amplifying
compartment of other epithelial cell populations where
an analogous differentiation hierarchy exists. It will thus
be of interest to elucidate the intrinsic and exogenous
factors that appear to link these changes to the control of
differentiation in normal human mammary cells.EXPERIMENTAL PROCEDURES
Cells and Colony-Forming Cell Assays
Histologically confirmed normal, anonymized tissue from
37 women undergoing cosmetic reduction mammoplasties
(Table S1) was obtained according to procedures approved by the
Stem Cell Reports
Telomere Dysfunction in Breast Luminal ProgenitorsUniversity of British Columbia Ethics Board and then processed
and cryopreserved in 6% DMSO-containing medium (Stingl
et al., 2005). Thawed cells were labeled with different fluoro-
chrome-conjugated antibodies (listed in Table S2) and DAPI
to enable highly purified subsets to be isolated by FACS (>95%
after a single sort and >98% after a second re-sort, as determined
by further flow cytometric analysis) using either an Influx-II or
ARIA FACS (Becton Dickinson) as described in detail previously
(Eirew et al., 2008). The same results were obtained from both
single- and double-sorted cells and therefore were pooled.
Colony-forming cell (CFC) assays were performed in dishes pre-
coated with 1.6% Matrigel (BD Biosciences) in SF7 medium with
5% fetal bovine serum (STEMCELL Technologies), 20 mM ROCK
inhibitor (Reagents Direct), and irradiated feeders.
Telomere Length Measurements
Genomic DNA isolated using QIAamp DNA Blood Mini Kits
(QIAGEN) was digested with HaeIII, HinfI, and RsaI, and DNA
fragments were separated by electrophoresis on 0.8% SeaKem LE
agarose gels (Lonza) and hybridized with 32P-labeled (TTAGGG)4.
Blots were scanned with a PhosphorImager (Molecular Dynamics)
and mean TRF lengths were determined (Huda et al., 2007,
2009). qPCR measurements (Cawthon, 2009) were performed in
triplicate in 15 ml reaction volumes with reaction conditions of
10 min at 94C, two cycles for 10 s each at 94C and 15 s at
49C, followed by 35 cycles at 94C for 10 s each, 62C for 15 s,
and 74C for 30 s with fluorescence signal acquisition. Automated
multicolor Flow-FISH was performed as previously described
(Baerlocher et al., 2006). Q-FISH with Cy3-labeled (CCCTAA)3
peptide nucleic acid (PNA) probes and analysis of telomere length
from digital images were performed as previously described (Poon
et al., 1999) on metaphases obtained from 3-day cultures (CFC
assay conditions) initiated with matched LPs and BCs (15 meta-
phases each) isolated from one of the samples used for southern
analysis.
TAR-Fusion PCR
Genomic DNA was isolated by the salt precipitation method,
and TAR-Fusion qPCR was carried out as previously described
(Tanaka et al., 2012) using a two-step touchdown PCR in a 20 ml
reaction mixture including 50 ng of DNA, multiple primers, 10%
7-Deaza-dGTP (Roche Diagnostics), and Advantage GC Genomic
LA PolymeraseMix (Clontech). To calculate the percentage of telo-
mere fusions detectable by TAR-Fusion PCR, we used the general
equation C(n, 2) + n, where n is the number of unique chromo-
somal ends. The total number of detectable fusion combinations
was 154 and the coverage rate was 14.2%.
TRAP Assays
TRAP assays were performed on 3-[(3-cholamidopropyl) dimethy-
lammonio]-1-propanesulfonate (CHAPS) extracts containing
0.25 mg of total protein using the TRAPeze telomerase detection
kit (Millipore), and PCR products were resolved by electrophoresis
in 12.5% polyacrylamide gels and visualized by SYBR Green
phosphorimaging as previously described (Herbert et al., 2006).
TRAP activity was then quantified using a LightCycler 480 II
(Roche) and cross-point (Cp) values were determined using thesecond derivative maximum method. These values were then
converted to protein concentrations (mg/mL) as an indicator of
telomerase activity by the fit-points method using LightCycler
480 software (1.5.0; Roche) and an HT1080 standard curve, and
then expressed as relative values using an extract of HeLa cells as
a reference.Confocal Laser Microscopy and Image Analysis
Cells were cytospun onto slides, rinsed with PBS, fixed with 4%
formaldehyde (Thermo Scientific, Rockland, IL, USA), permeabi-
lized with 0.2% Triton X-100 (Sigma-Aldrich, St. Louis, MO,
USA), and blocked with 6% BSA (Fraction V; Fisher Scientific) in
PBS. The cells were then incubated with various antibodies at
room temperature for 1 hr, washed in PBS, and incubated with
secondary antibodies (listed in Table S2) as recommended by
the manufacturer. After further washing with PBS, nuclei were
labeled with SYTOX Blue (Invitrogen), mounted with Qmount
(Invitrogen), and imaged on an Olympus FV1000MPE confocal/
multiphoton microscope using FV-ASW 3.0 Viewer software.qRT-PCR
Complementary DNA (cDNA) was generated from Trizol extracts
using the Quantiscript RT Fastlane cDNA kit (QIAGEN). The
primers used for qRT-PCR are listed in Table S3. Samples were
subjected in triplicate to 40 amplification cycles (10 s at 95C,
20 s at 60C, and 30 s at 72C). Two negative controls (one
in which no cDNA template was added and one in which no
RT treatment was applied) were included in each experiment.
Gene transcript levels were calculated using the DDCt method
(Livak and Schmittgen, 2001), with TATA box-binding protein
(TBP) expression used as a loading control.Microarray Analysis
RNA in Trizol was repurified using the RNeasyMicro kit (QIAGEN),
and preparations with an RNA integrity number of R8.0 were
prepared using the Agilent One-Color Microarray-Based Exon
Analysis Low Input Quick Amp WT Labeling Kit v1.0. Aliquots
of 25 ng total RNA were used to generate Cyanine-3-labeled
complementary RNA, which was then hybridized on 8 3 60K
Agilent Whole Human Genome Oligo Microarrays (Design ID
028004) and scanned at 3 mm resolution in an Agilent DNA
microarray scanner and data processed using Agilent Feature
Extraction 10.10. The processed signal was quantile normalized
with Agilent GeneSpring 11.5.1 and analyzed using the open-
source language R.ACCESSION NUMBERS
The GEO accession number for the transcriptome data sets
reported in this paper is GSE37223.SUPPLEMENTAL INFORMATION
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